Many people living with rheumatoid arthritis (RA) rely on long-term medications to manage joint pain, stiffness, and inflammation. A number of these treatments are given as subcutaneous injections, ...

In this video, we cover a full performance upgrade workflow, including a port injection conversion, essential AN hose assembly tips, and dyno tuning at FiTech for maximum power and reliability. You’ll ...

A newly developed autoinjector is described as a “major leap forward in how autoinjectors are developed, customized, and scaled,” according to contract development and manufacturing organization (CDMO ...

As part of the back-to-school rush, GoodRx, a platform for medication savings, reports the demand for epinephrine (EpiPen, EpiPen Jr, Adrenaclick, Auvi-Q) auto-injectors tends to spike in the summer ...

If approved, ReadyFlow Autoinjector would deliver an IV-equivalent diuretic dose (subcutaneous furosemide injection 80 mg/ml) in under 10 seconds Would potentially provide a cost-effective and ...

A Prescription Drug User Fee Act target date of July 26, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Application ...

TOLEDO, Ohio — Stellantis has announced a major investment in Toledo’s auto industry, confirming plans to build an all-new midsize truck at the Toledo Assembly Complex. The automaker says the ...

Auto-injector specialist Ypsomed is hopping on the U.S. manufacturing bandwagon, investing 200 million Swiss francs ($248 million) to build a plant in Holly Springs, North Carolina. It will be the ...

Patients with mild to moderate Alzheimer’s disease can now treat themselves at home with the latest drug for the neurodegenerative disease. In August, the FDA approved the first self-injectable form ...

Major auto parts maker First Brands Group, LLC. filed for bankruptcy protection over the weekend — revealing billions of mounting debt in the process. The auto parts manufacturing company filed for ...

Biogen (NASDAQ:BIIB) and Eisai (OTCPK:ESAIY) announced the rolling submission of a marketing application to receive an FDA label expansion for a subcutaneous autoinjector that delivers their Alzheimer ...